Antibody Licensing Deals in China: H1 2021 Summary
Minhua Chu · 07/29/2021
Nineteen antibody deals were closed in H1 2021.
READ MORE
Do NMPA Approvals Cause Share Prices to Rise?
Shi Yingzi · 07/29/2021
three fourths of stocks to rise on the day of approval.
READ MORE
The Chinese Government is Taking Initiatives to Enha...
editor · 07/19/2021
Improve the system of laws and regulations. Speed up their formulation and revision and advance technical guidelines in an orderly manner.
READ MORE
The Advantages of Getting Breakthrough Therapy Desig...
editor · 07/19/2021
On July 1, 2020, the latest Drug Registration Regulations were enacted. This new set of regulations introduced four accelerated procedures for BTDs therapy, conditional approval, priority review and approval, and special approval.
READ MORE
Will China’s Capital Market Get Better in 2021?
Xu Weijia · 07/19/2021
As a weathervane of China Biotech, CES HK Biotechnology Index (CES HK Biotech) roseby 9.51% in January, By comparison, A-shares of the China Securities Medicine Index has been rising at 5.02%, the Shanghai and Shenzhen 300 Index had a growth rate at 2.7% and the Hang Seng Index (HSI) had a 3.87% growth.
READ MORE
New CDE Guidelines Spur a Market Panic
Minhua Chu · 07/19/2021
Now, oncology is the hot field in drug development. Therefore, the CDE wants to guide clincial development through the document, emphasis the concept of clincial value-oriented, and implement the ICH PFDD guidelines through the document.
READ MORE
Key Takeaways from the CDE's 2020 Annual Drug Evalua...
Minhua Chu · 07/19/2021
The amounts to a total increase of 32.67% from 2019 despite the pandemic.
READ MORE
Kintor‘s Cancer Drug Reduces COVID-19 Mortality Ris...
Minhua Chu · 07/19/2021
Its nonsteroidal antiandrogen candidate proxalutamide reduced mortality risk by 92% and shortened the median length of hospital stays by nine days, according to an investigator-initiated trial conducted in Brazil.
READ MORE
Germany’s Merck Brings Next Wave of Oncology Blockb...
· 07/19/2021
To shake up cancer SOC.
READ MORE
READ MORE
Copyright © 2016-2021 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement